Use of Lactobacillus Acidophilus R0052 and Lactobacillus Rhamnosus R0011 Probiotic Strains in Children with Burn Injuries

M.V. Patsera, Ya.S. Skrypnykova, O.H. Ivan’ko

Abstract


Today, burn injury is second most frequent diagnosis in all children hospitalized with injuries. The main cause of death in cases of extensive deep burns is burn infection that occurs in 23 to 82 % of all burn units’ patients. Antibacterial treatment rationality is of great importance in fighting the generalized infections. This paper is aimed at scrutinizing the incidence and course characteristics of the antibiotic-associated diarrhea (AAD) in burn patients, as well as the possibility of its prevention in children receiving antibacterial treatment in the Regional Burn Unit of Zaporizhzhia. During 2012–2015, we have observed 438 children with burn injuries, who received antibio­tics. We observed children receiving antibiotics and examined over hospitalization time by detection of the highly specific for antibiotic-associated diarrhea A + B Clostridium difficile toxins in stool, which allowed diagnosing the enterocolitis due to Clostridium difficile associated with antibiotics administration (A4.07, ICD‑10). AAD prevention methods have been developed, among which preventive (from the first hours of hospitalization) administration of oral probiotic agent containing Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 probiotic strains as a part of the Lacidofil® preparation dosed by age should be considered a major one. Prophylactic prescription of probiotic strains with antitoxic action against Clostridium difficile had reduced the incidence of antibiotic-associated diarrhea in children and the severity of its symptoms by 3.4 times.


Keywords


children; burn injury; antibiotic-associated diarrhea; Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 probiotic strains

Full Text:

PDF

References


Fistal E.Y., Kozinets G.P., Samoilenko G.E., Nosenko V.M. Pediatricheskaia kombustiologia: rukovodstvo dlia vrachei [Pediatric combustiology: the doctors’ study guide]. — ​Donetsk: Veber, 2007. — ​Р. 233.

Krutikov M.G., Bobrovnikov A.E. Preventive antibiotics in combustiology (literature review) // Combustiology journal (electronic version). — 2000. — № 4.

Krutikov M.G. Infection issues in burn patients (literature review) // Combustiology journal (electronic version). — 2002. — № 10.

Amsden G.W., Mandell G.L., Bennet J.E. Tables of antimicrobial agent pharmacology // Principles and Practice of Infectious Diseases. — 5th ed. — ​Philadelphia etc.: Churchill Livingstone, 2000. — ​Р. 566-589.

Radutna O.A. Infektsionno-zavisimye mekhanizmy kishechnykh oslozhneniy, razvivaiushchikhsia vo vremia lechenia antibiotikami u detei [Infection-dependent mechanisms of intestinal complications development during antibiotic treatment in children] // Zaporozhskii Meditsinskii Zhurnal — ​Zaporizhzhia Medical Journal. — 2011. — ​Іssue 13, № 4. — ​Р. 40-43.

Ivanko O., Radutna H. Lacidofil® in prevention of antibio­tic-associated diarrhea caused by Clostridium difficile infection // Annual Scientific Exchange. — 2005, Sept. 7–8. — ​Rome: Institut Rosell, 2005. — ​Р. 32-34.

Lewis S.J., Heaton K.W. Stool form scale as a useful guide to intestinal transit time // Scand. J. of Gastroenter. — 1997. — ​Vol. 32. — ​Р. 920-924.

Chernyshova L.I., Samarin D.V., Kramarev C.O. Gostri kyshkovi infektsii u ditey [Acute intestinal infections in children]. — ​Kyiv, 2006. — 163 p.

Ivanko O.H., Patsera M.V., Radutna O.A. Klinichna kharakterystyka ta mekanizmy formuvannia urazhen kishechnykhu pid chas terapii antybiotykamy u ditei. Proekt robochoi klasyfikatsii [Clinical characteristics and mechanisms of intestinal injuries formation during antibiotic treatment in children. Project of operating classification] // Pediatria, akusherstvo ta ginekologia — ​POG. — 2011. — ​Vol. 73, № 1. — ​Р. 33-39.

Pelleschi M.E. Clostridium difficile-Associated Disease // Critical Care Nurse. — 2008. — ​Vol 28(1). — ​P. 27-35.

Johnston B.C., Supina A.L., Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials // CMAJ. — 2006. — ​Vol. 175, № 4. — ​Р. 377-383.

Chapman C.M., Gibson G.R., Rowland І. Health benefits of probiotics: are mixtures more effective than single strains? // European Journal of Nutrition. — 2011. — ​Vol. 50, № 1. — ​Р. 1-17.

Kotowska M., Albrecht P., Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial // Ali­ment. Pharmacol. Ther. — 2005. — ​Vol. 21, № 5. — ​Р. 583-590.

Finegold S.M., Mathisen G.E. Metronidazole // Principles and Practice of infectious diseases / Mandell, Douglas, Bennett. — 3rd ed. — ​Edinburgh, London, Melbourne, 1990. — ​Р. 303-308.

Hempel S. et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis // Journal of the American Medical Association. — 2012. — ​Vol. 307, № 18. — ​Р. 1959-1969.

Ivanko O.H., Patsera M.V., Shalmin A.S., Chernyshova L.I. Ispolzovanie probioticheskikh shtammov Lactobacillus acidophilus R0052 i Lactobacillus rhamnosus R0011 pri legochnom tuberkuleze u detei, oslozhnennom antibiotic-assotsiirovannoi Clostridium difficile kishechnoi infektsiei. [Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 probiotic strains against pulmonary tuberculosis complicated by antibiotic-associa­ted Clostridium difficile intestinal infection in children] // Zaporozhskii Meditsinskii Zhurnal — ​Zaporizhzhia Medical Journal. — 2010. — № 3. — ​Р. 30-33.

Fisher M. Pseudomembranous Colitis: Nelson Textbook of Pediatrics. — 18th ed. — ​Kliegman, 2008. — ​www.mdconsult.com

Dial S., Jayaraman D., Tompkins T., Menzies D. Evaluation of the effectiveness of the probiotic lacidofil in the prevention of antibiotic associated diarrhea: pilot study for a randomized controlled trial. Annual Scientific Exchange 2003. Summary of probiotic Presentations&Poster abstracts, Institut Rosell — ​Lallemand Nutrition Group. — ​Р. 31-33.

Del Piano M., et al. Is microencapsulation the future of probiotic preparations? The increased efficacy of gastro-protected probiotics // Gut Microbes. — 2011. — ​Vol. 2, № 2. — ​Р. 120-123.

Foster L.M., Tompkins T.A., Dahl W.J. A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011 // Beneficial Microbes. — ​2011. — ​Vol. 2, № 4. — ​Р. 319-334.




DOI: https://doi.org/10.22141/2308-2097.4.62.2016.81095

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru